Passa al contenuto
Merck
  • Hypoxia-induced miR-210 in epithelial ovarian cancer enhances cancer cell viability via promoting proliferation and inhibiting apoptosis.

Hypoxia-induced miR-210 in epithelial ovarian cancer enhances cancer cell viability via promoting proliferation and inhibiting apoptosis.

International journal of oncology (2014-04-10)
Li'an Li, Ke Huang, Yanqin You, Xiaoyu Fu, Lingyun Hu, Lei Song, Yuanguang Meng
ABSTRACT

miR-210 is upregulated in a HIF-1α-dependent way in several types of cancers. In addition, upregulated miR-210 promotes cancer proliferation, via its anti-apoptotic effects. It is blind to the regulation of miR-210 under hypoxia conditions for ovarian cancer cells and to the effect of miR-210 on ovarian cancer growth. In the present study, we determined the expression of miR-210 in epithelial ovarian cancer specimens, and in ovarian cancer cell lines under hypoxia conditions, and determined in detail the effect of miR-210 overexpression on tumor cell proliferation, and the possible mechanisms of tumor growth by miR-210 regulation. It was shown that miR-210 expression is upregulated, in response to hypoxia conditions in epithelial ovarian cancer specimens as well as epithelial ovarian cancer cell lines, with an association to HIF-1α overexpression. Furthermore, upregulated miR-210 promoted tumor growth in vitro via targeting PTPN1 and inhibiting apoptosis. Therefore, our findings shed light on the mechanism of ovarian cancer adaptation to hypoxia.

MATERIALI
N° Catalogo
Marchio
Descrizione del prodotto

Sigma-Aldrich
Ioduro di propidio, ≥94.0% (HPLC)
Sigma-Aldrich
5-Fluorouracil, ≥99% (HPLC), powder
Sigma-Aldrich
Propidium iodide solution
Sigma-Aldrich
Ioduro di propidio, ≥94% (HPLC)
Supelco
Fluorouracil, Pharmaceutical Secondary Standard; Certified Reference Material
USP
Fluorouracil, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
Fluorouracil, meets USP testing specifications
Supelco
5-Fluorouracil, analytical standard
Fluorouracil, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
Monoclonal Anti-CASP9 antibody produced in mouse, clone 3B8-4G2, purified immunoglobulin, buffered aqueous solution